Advertisement
Guidelines and Guidance

Guidelines and Guidance The Guidelines and Guidance section contains advice on conducting and reporting medical research.

See all article types »

Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research

  • Ewout W. Steyerberg ,

    Affiliation: Department of Public Health, Erasmus MC, Rotterdam, Netherlands

    These authors contributed equally and are joint first authors on this work.

    X
  • Karel G. M. Moons ,

    Affiliation: Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, Netherlands

    These authors contributed equally and are joint first authors on this work.

    X
  • Danielle A. van der Windt,

    Affiliation: Arthritis Research UK Primary Care Centre, Keele University, Keele, United Kingdom

    X
  • Jill A. Hayden,

    Affiliation: Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada

    X
  • Pablo Perel,

    Affiliation: London School of Hygiene & Tropical Medicine, London, United Kingdom

    X
  • Sara Schroter,

    Affiliation: BMJ, BMA House, Tavistock Square, London, United Kingdom

    X
  • Richard D. Riley,

    Affiliation: School of Health and Population Sciences, University of Birmingham, Birmingham, United Kingdom

    X
  • Harry Hemingway,

    Affiliation: Department of Epidemiology and Public Health, University College London, London, United Kingdom

    X
  • Douglas G. Altman mail,

    doug.altman@csm.ox.ac.uk

    Affiliation: Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom

    X
  • for the PROGRESS Group
  • Published: February 05, 2013
  • DOI: 10.1371/journal.pmed.1001381

About the Authors

Ewout W. Steyerberg
Department of Public Health, Erasmus MC, Rotterdam, Netherlands
Karel G. M. Moons
Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, Netherlands
Danielle A. van der Windt
Arthritis Research UK Primary Care Centre, Keele University, Keele, United Kingdom
Jill A. Hayden
Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada
Pablo Perel
London School of Hygiene & Tropical Medicine, London, United Kingdom
Sara Schroter
BMJ, BMA House, Tavistock Square, London, United Kingdom
Richard D. Riley
School of Health and Population Sciences, University of Birmingham, Birmingham, United Kingdom
Harry Hemingway
Department of Epidemiology and Public Health, University College London, London, United Kingdom
Douglas G. Altman
Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom

Corresponding Author

Email: doug.altman@csm.ox.ac.uk

Competing Interests

SS is a full time employee of the BMJ Group but is not involved in the decision making on manuscripts. The authors declare no other competing interests.

Author Contributions

Wrote the first draft of the manuscript: EWS KGMM. Contributed to the writing of the manuscript: EWS KGMM DAvdW JAH PP SS RDR HH DGA. Initiated the PROGRESS Group, organised the three workshops, coordinated the writing groups, and were the scientific writing editors for all the papers in the PROGRESS series: HH RDR SS DGA. Guarantors for this paper: HH RDR DGA. Contributed through workshops and discussions to the development of the article series: PROGRESS Group.ICMJE criteria for authorship read and met: EWS KGMM DAvdW JAH PP SS RDR HH DGA. Agree with manuscript results and conclusions: EWS KGMM DAvdW JAH PP SS RDR HH DGA.